Evidence map

ReviewAsian journal of pharmaceutical sciences2025

Advances in nanotechnology for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease.

Fenfen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40182137